Table 2:
Surgical treatment of patients with negative and positive cytology.
| Negative cytology at PIPAC#1 n=31 patients | Positive cytology at PIPAC#1 n=44 patients | p-Value | |
|---|---|---|---|
| Surgical details | |||
| Number PIPAC per patients, n (%) | 0.23 | ||
| 1–2 PIPAC | 25 (80 %) | 30 (68 %) | |
| 3 PIPAC | 4 (13 %) | 11 (25 %) | |
| >3 PIPAC | 2 (6 %) | 3 (7 %) | |
| per protocol (≥3 PIPAC) | 6 (19 %) | 14 (32 %) | 0.23 |
| Median ascites volume during PIPAC, mL (IQR) | 0 (0–100) | 100 (0–1,075) | 0.01 |
| Median PCI (IQR) | 9 (3–18) | 19 (11–27) | <0.01 |
| Mean of PGRS, median (IQR) | 2 (1–2) | 2 (2–3) | 0.10 |
| Intraoperative complications, n (%) | 2 (6 %) | 2 (5 %) | 0.44 |
| Cytology origin | 0.01 | ||
| Ascites, n (%) | 9 (29 %) | 27 (62 %) | |
| Peritoneal lavage, n (%) | 22 (71 %) | 17 (38 %) |
Median (IQR, interquartile rang or range), mean (SD, standard deviation) or number (%) as appropriate. Statistical significance (p<0 05) is highlighted in bold. ASA, American Association of Anesthesiologists physical status classification system; ECOG Performance Status Scale; PCI, Peritoneal Cancer Index; PRGS, Peritoneal Regression Grading Score.